Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apple Tree Partners (ATP) is a premier life sciences venture capital firm and venture studio that specializes in creating and building companies to develop transformative medicines. Founded in 1999 and headquartered in New York, the firm operates with a unique "company builder" model, providing both significant financial capital and deep operational leadership to its portfolio companies from their inception. ATP focuses on a broad range of therapeutic areas, including oncology, metabolic diseases, neurology, and genetic medicines, utilizing diverse modalities such as small molecules, RNA editing, and advanced delivery systems. The firm is known for internalizing the early stages of drug discovery and development, often spinning out independent entities once they reach key clinical or technical milestones. Notable companies founded or incubated by ATP include Akero Therapeutics, Acrivon Therapeutics, and Aera Therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Accelerated Technology Partners.